Table 3 Parameter associations with the combined endpoint.

From: Application of urinary peptide-biomarkers in trauma patients as a predictive tool for prognostic assessment, treatment and intervention timing

Characteristic

no EP, N = 9

EP, N = 7

p value*

Age (years), mean ± SD

43 ± 15

49 ± 28

0.8

Female gender, n (%)

5 ± 56%

3 ± 43%

 > 0.9

Lactate (mmol/l), mean ± SD

2.19 ± 1.59

3.33 ± 2.15

0.12

C-reactive protein (mg/dl), mean ± SD

1.2 ± 0.8

5.5 ± 6.5

0.3

Haemoglobin (g/dl), mean ± SD

11.83 ± 2.88

11.66 ± 2.24

 > 0.9

CKD273, mean ± SD

-0.27 ± 0.61

0.58 ± 0.25

0.004

AKI204, mean ± SD

-0.65 ± 0.91

0.45 ± 0.51

0.029

Cov50, mean ± SD

-0.80 ± 1.46

0.61 ± 0.45

0.094

APACHE 1.day, mean ± SD

10 ± 10

14 ± 6

0.4

RISC II, mean ± SD

7 ± 10

15 ± 16

0.4

ISS, mean ± SD

22 ± 12

34 ± 17

0.3

TRISS, mean ± SD

65 ± 39

45 ± 38

0.2

SAPS II, mean ± SD

29 ± 16

35 ± 11

0.7

TIPS, mean ± SD

12 ± 7

21 ± 10

0.13

  1. EP =Endpoint, *Wilcoxon rank-sum test (for continuous variables); Fisher’s exact test (for categorical variables).
  2. Significant are in value [bold].
Back to article page